Aktienanalyse zu Exponent Inc (EXPO)EXPOExponent Inc

Exponent, Inc., together with its subsidiaries, is a science and engineering consulting firm that provides solutions to complex problems. The Company’s segments include Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and their impact on both human health and the environment. It serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation and other sectors of the economy. The Company’s service offerings are provided on a project-by-project basis. It operates in the Industrials sector (SERVICES-MANAGEMENT CONSULTING SERVICES industry).

Exponent Inc is a good buy right now, trading at $69.81, with a strong recent performance reflected in a 21% year-over-year revenue growth in Q2 2026 and a solid EPS of $0.60, which beat expectations by $0.05. The stock has an RSI of 67.123, indicating it is nearing overbought territory but still has momentum. The main risk is its forward P/E of 31.55, which suggests it may be overvalued if growth does not continue as expected.

4 analysts cover EXPO: 1 rate it Buy, 3 Hold and 0 Sell. The average price target is 85.50.